0.15Open0.15Pre Close0 Volume36 Open Interest20.00Strike Price0.00Turnover6405.36%IV14.62%PremiumOct 18, 2024Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type0.1465Delta0.1096Gamma117.20Leverage Ratio-187.4486Theta0.0000Rho17.17Eff Leverage0.0001Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet